These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23129075)

  • 1. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU; Kutty PK; Hudson JM; Blog D; Abedi GR; Goodell S; Lawler J; McLean HQ; Pollock L; Rausch-Phung E; Schulte C; Valure B; Armstrong GL; Gallagher K
    Pediatrics; 2012 Dec; 130(6):e1567-74. PubMed ID: 23129075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak.
    Abedi GR; Mutuc JD; Lawler J; Leroy ZC; Hudson JM; Blog DS; Schulte CR; Rausch-Phung E; Ogbuanu IU; Gallagher K; Kutty PK
    Vaccine; 2012 Nov; 30(49):7052-8. PubMed ID: 23041123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
    Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
    N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K; Bunce A
    Epidemiol Infect; 2012 Sep; 140(9):1612-6. PubMed ID: 22117122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.
    Nelson GE; Aguon A; Valencia E; Oliva R; Guerrero ML; Reyes R; Lizama A; Diras D; Mathew A; Camacho EJ; Monforte MN; Chen TH; Mahamud A; Kutty PK; Hickman C; Bellini WJ; Seward JF; Gallagher K; Fiebelkorn AP
    Pediatr Infect Dis J; 2013 Apr; 32(4):374-80. PubMed ID: 23099425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mumps vaccine performance among university students during a mumps outbreak.
    Cortese MM; Jordan HT; Curns AT; Quinlan PA; Ens KA; Denning PM; Dayan GH
    Clin Infect Dis; 2008 Apr; 46(8):1172-80. PubMed ID: 18444852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing outbreak of mumps infection in Oban, Scotland, November 2010 to January 2011.
    Walker J; Huc S; Sinka K; Tissington A; Oates K
    Euro Surveill; 2011 Feb; 16(8):. PubMed ID: 21371413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.
    Livingston KA; Rosen JB; Zucker JR; Zimmerman CM
    Vaccine; 2014 Jan; 32(3):369-74. PubMed ID: 24252695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
    Cohen C; White JM; Savage EJ; Glynn JR; Choi Y; Andrews N; Brown D; Ramsay ME
    Emerg Infect Dis; 2007 Jan; 13(1):12-7. PubMed ID: 17370510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine.
    American Academy of Pediatrics. Committee on Infectious Diseases
    Pediatrics; 1998 Jan; 101(1 Pt 1):129-33. PubMed ID: 11345975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Departments' Experience With Mumps Outbreak Response and Use of a Third Dose of Measles, Mumps, and Rubella Vaccine.
    Marlow MA; Moore K; DeBolt C; Patel M; Marin M
    J Public Health Manag Pract; 2020; 26(2):101-108. PubMed ID: 30807465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
    J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
    Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.